Information for
Nurses and Technicians

The Benefits of Chlorhexidine

Chlorhexidine is a broad-spectrum disinfectant and antiseptic that significantly reduces the occurrence of CLABSI-causing pathogens.1

What is Chlorhexidine?

Understand the properties of chlorhexidine to support strategies to reduce central line-associated bloodstream infections (CLABSI).

Available in Max
Barrier Kits

Arrowg+ard Blue Advance™
PICCs and Midline kits
have the components you need
for bedside insertion
,
designed to help save you
valuable prep time
.

Protecting Areas
Clinically Out of Reach1,2

Arrowg+ard Blue
Advance™ Catheters with
chlorhexidine are proven to
reduce CLABSI-causing
pathogens by 99.99%

for at least 30 days.3

Antithrombogemic
Properties2

Chlorhexidine in
Arrowg+ard Blue Advance™
Catheters also works
continuously to prevent
catheter buildup
of
fibrin sheath, reducing
the risk of intraluminal
thrombotic occlusion
.2

When you think Antimicrobial Protection, think BLUE

99.99% Colonization Reduction

in gram-positive and gram-negative bacterial and fungal pathogens for at least 30 days.3
Products may not be available in all countries. Midline with Arrowg+ard protection is currently not available in the EMEA region.
Please contact your local representative.

See the Difference Arrowg+ard Blue Advance™ Protection Makes4,5

Your Vascular
Access Partner

Your Vascular Access Partner

At Teleflex, we share your
commitment to patient safety.

We work with you to provide hands-on training and bedside coaching.

Chlorhexide Sensitivity Information

Webinar Resources

Would you like to download our informational material?

Download brochure

Contact us

Teleflex is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. Please review the Teleflex Privacy Policy.

References:

  1. Ryder MA, et al. Reduction of Extraluminal Bacterial Colonization Using Chlorhexidine Antimicrobial-coated PICC Catheters in a Clinically Simulated Ovine Model. Infusion Nurses Society Annual Convention and Industrial Exhibition; 2012.
  2. Ryder MA, et al. The Effect of Chlorhexidine Catheter Coating Compared to an Uncoated and Biomimetic Catheter on the Reduction of Fibrin Sheath Formation in an in vivo Clinically Simulated Ovine Model. Infusion Nurses Society Annual Convention and Industrial Exhibition; 2012.
  3. In vitro data on file 2010: AVER-004371 and AVER-004483. No correlation between in vitro/in vivo testing methods and clinical outcomes has currently been ascertained.
  4. Mermel LA. What is the evidence for intraluminal colonization of hemodialysis catheters?. Kidney Int. 2014;86(1):28-33. doi:10.1038/ki.2013.527
  5. O’Grady NP, Alexander M, Burns LA, et al; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections, 2011. CDC. Updated October 2017. Accessed January 29, 2024. https://www.cdc.gov/infectioncontrol/pdf/guidelines/bsi-guidelines-H.pdf

Contraindications:

Clinical assessment of the patient must be completed to ensure no contraindications exist. Arrowg+ard Blue Advance™ Catheters are contraindicated in the following areas:

No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.

Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue, Arrowg+ard Blue Advance, and Arrowg+ard Blue Plus are trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners. MCI-102066

Contacts